|
1
|
Chanal E, Bouleftour W, Rivoirard R, Bosaki C, Forges F, Jacquin JP, Fournel P, Mery B, Saban-Roche L. [Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases]. Presse Med 2019; 48:1026-1031. [PMID: 31653541 DOI: 10.1016/j.lpm.2019.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Revised: 08/01/2019] [Accepted: 08/14/2019] [Indexed: 10/25/2022] Open
Affiliation(s)
- Edouard Chanal
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Wafa Bouleftour
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France.
| | - Romain Rivoirard
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Claire Bosaki
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Fabien Forges
- Institut de cancérologie Lucien-Neuwirth, département de pharmacie, 42271 Saint-Priest-en-Jarez, France
| | - Jean-Philippe Jacquin
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Pierre Fournel
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Benoite Mery
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| | - Léa Saban-Roche
- Institut de cancérologie Lucien-Neuwirth, département d'oncologie médicale, 108, bis avenue Albert-Raimond, 42271 Saint Priest en Jarez, France
| |
Collapse
|
|
2
|
Kim D. Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer. Clin Case Rep 2019; 7:935-938. [PMID: 31110718 PMCID: PMC6509889 DOI: 10.1002/ccr3.2122] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 01/03/2019] [Accepted: 03/04/2019] [Indexed: 12/19/2022] Open
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a neurological syndrome characterized by vasogenic cerebral edema with predominantly posterior involvement. Uncontrolled severe hypertension and endothelial dysfunction have been implicated as two main mechanisms. Clinicians should notice the development of PRES in hypertensive patients accompanying neurological changes, such as impaired vision and consciousness.
Collapse
Affiliation(s)
- Dohhyung Kim
- Division of Pulmonary Medicine and AllergyDepartment of Internal MedicineDankook University HospitalDankook University College of MedicineCheonanKorea
| |
Collapse
|